188 related articles for article (PubMed ID: 21111489)
1. Augmentation of regulatory B cell activity in experimental allergic encephalomyelitis by glatiramer acetate.
Begum-Haque S; Christy M; Ochoa-Reparaz J; Nowak EC; Mielcarz D; Haque A; Kasper LH
J Neuroimmunol; 2011 Mar; 232(1-2):136-44. PubMed ID: 21111489
[TBL] [Abstract][Full Text] [Related]
2. The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice.
Aharoni R; Eilam R; Domev H; Labunskay G; Sela M; Arnon R
Proc Natl Acad Sci U S A; 2005 Dec; 102(52):19045-50. PubMed ID: 16365293
[TBL] [Abstract][Full Text] [Related]
3. Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ.
Aharoni R; Kayhan B; Eilam R; Sela M; Arnon R
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14157-62. PubMed ID: 14614135
[TBL] [Abstract][Full Text] [Related]
4. B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis.
Kala M; Rhodes SN; Piao WH; Shi FD; Campagnolo DI; Vollmer TL
Exp Neurol; 2010 Jan; 221(1):136-45. PubMed ID: 19879259
[TBL] [Abstract][Full Text] [Related]
5. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis.
Matsushita T; Horikawa M; Iwata Y; Tedder TF
J Immunol; 2010 Aug; 185(4):2240-52. PubMed ID: 20624940
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of B cell-associated regulatory cytokines by glatiramer acetate in mice with experimental autoimmune encephalomyelitis.
Begum-Haque S; Sharma A; Christy M; Lentini T; Ochoa-Reparaz J; Fayed IF; Mielcarz D; Haque A; Kasper LH
J Neuroimmunol; 2010 Feb; 219(1-2):47-53. PubMed ID: 20034680
[TBL] [Abstract][Full Text] [Related]
7. Glatiramer acetate biases dendritic cells towards an anti-inflammatory phenotype by modulating OPN, IL-17, and RORγt responses and by increasing IL-10 production in experimental allergic encephalomyelitis.
Begum-Haque S; Christy M; Wang Y; Kasper E; Ochoa-Reparaz J; Smith JY; Haque A; Kasper LH
J Neuroimmunol; 2013 Jan; 254(1-2):117-24. PubMed ID: 23141166
[TBL] [Abstract][Full Text] [Related]
8. IFN-β treatment requires B cells for efficacy in neuroautoimmunity.
Schubert RD; Hu Y; Kumar G; Szeto S; Abraham P; Winderl J; Guthridge JM; Pardo G; Dunn J; Steinman L; Axtell RC
J Immunol; 2015 Mar; 194(5):2110-6. PubMed ID: 25646307
[TBL] [Abstract][Full Text] [Related]
9. Restoration of axon conduction and motor deficits by therapeutic treatment with glatiramer acetate.
Moore S; Khalaj AJ; Patel R; Yoon J; Ichwan D; Hayardeny L; Tiwari-Woodruff SK
J Neurosci Res; 2014 Dec; 92(12):1621-36. PubMed ID: 24989965
[TBL] [Abstract][Full Text] [Related]
10. Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis.
Gentile A; Rossi S; Studer V; Motta C; De Chiara V; Musella A; Sepman H; Fresegna D; Musumeci G; Grasselli G; Haji N; Weiss S; Hayardeny L; Mandolesi G; Centonze D
J Neuroimmune Pharmacol; 2013 Jun; 8(3):651-63. PubMed ID: 23370991
[TBL] [Abstract][Full Text] [Related]
11. Complexity of trophic factor signaling in experimental autoimmune encephalomyelitis: differential expression of neurotrophic and gliotrophic factors.
Song F; Bandara M; Deol H; Loeb JA; Benjamins J; Lisak RP
J Neuroimmunol; 2013 Sep; 262(1-2):11-8. PubMed ID: 23763772
[TBL] [Abstract][Full Text] [Related]
12. Helminth-induced CD19+CD23hi B cells modulate experimental allergic and autoimmune inflammation.
Wilson MS; Taylor MD; O'Gorman MT; Balic A; Barr TA; Filbey K; Anderton SM; Maizels RM
Eur J Immunol; 2010 Jun; 40(6):1682-96. PubMed ID: 20306466
[TBL] [Abstract][Full Text] [Related]
13. CD4(+)CD25(+) regulatory T cells contribute to the therapeutic effects of glatiramer acetate in experimental autoimmune encephalomyelitis.
Jee Y; Piao WH; Liu R; Bai XF; Rhodes S; Rodebaugh R; Campagnolo DI; Shi FD; Vollmer TL
Clin Immunol; 2007 Oct; 125(1):34-42. PubMed ID: 17632037
[TBL] [Abstract][Full Text] [Related]
14. TLR9 mediated regulatory B10 cell amplification following sub-total body irradiation: Implications in attenuating EAE.
Hong J; Fang J; Lan R; Tan Q; Tian Y; Zhang M; Okunieff P; Zhang L; Lin J; Han D
Mol Immunol; 2017 Mar; 83():52-61. PubMed ID: 28110075
[TBL] [Abstract][Full Text] [Related]
15. Oestrogen-mediated protection of experimental autoimmune encephalomyelitis in the absence of Foxp3+ regulatory T cells implicates compensatory pathways including regulatory B cells.
Subramanian S; Yates M; Vandenbark AA; Offner H
Immunology; 2011 Mar; 132(3):340-7. PubMed ID: 21091909
[TBL] [Abstract][Full Text] [Related]
16. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
[TBL] [Abstract][Full Text] [Related]
17. Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of action.
Lalive PH; Neuhaus O; Benkhoucha M; Burger D; Hohlfeld R; Zamvil SS; Weber MS
CNS Drugs; 2011 May; 25(5):401-14. PubMed ID: 21476611
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging characterization of different experimental autoimmune encephalomyelitis models and the therapeutic effect of glatiramer acetate.
Aharoni R; Sasson E; Blumenfeld-Katzir T; Eilam R; Sela M; Assaf Y; Arnon R
Exp Neurol; 2013 Feb; 240():130-44. PubMed ID: 23153580
[TBL] [Abstract][Full Text] [Related]
19. Glatiramer acetate increases T- and B -regulatory cells and decreases granulocyte-macrophage colony-stimulating factor (GM-CSF) in an animal model of multiple sclerosis.
Aharoni R; Eilam R; Schottlender N; Radomir L; Leistner-Segal S; Feferman T; Hirsch D; Sela M; Arnon R
J Neuroimmunol; 2020 Aug; 345():577281. PubMed ID: 32534388
[TBL] [Abstract][Full Text] [Related]
20. Regulatory T Cell Dysfunction Acquiesces to BTLA+ Regulatory B Cells Subsequent to Oral Intervention in Experimental Autoimmune Encephalomyelitis.
Huarte E; Jun S; Rynda-Apple A; Golden S; Jackiw L; Hoffman C; Maddaloni M; Pascual DW
J Immunol; 2016 Jun; 196(12):5036-46. PubMed ID: 27194787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
